Epirubicin Hydrochloride Market

Epirubicin Hydrochloride is the hydrochloride salt of the 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.
Epirubicin Hydrochloride Market contains market size and forecasts of Epirubicin Hydrochloride in global, including the following market information:
Global Epirubicin Hydrochloride Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Epirubicin Hydrochloride Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Epirubicin Hydrochloride companies in 2021 (%)
The global Epirubicin Hydrochloride market was valued at 260.5 million in 2021 and is projected to reach US$ 219.9 million by 2028, at a CAGR of -2.4% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10mg/5ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Epirubicin Hydrochloride include Sterling Biotech, Zhejiang Hisun Pharma, Flavine, Teva API, Microbiopharm Japan, DZD Heze Pharma, Synbias Pharma, Intas Pharma and Humble Healthcaare, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Epirubicin Hydrochloride manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epirubicin Hydrochloride Market, by Package, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Epirubicin Hydrochloride Market Segment Percentages, by Package, 2021 (%)
10mg/5ml
50mg/25ml
Other
Global Epirubicin Hydrochloride Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Epirubicin Hydrochloride Market Segment Percentages, by Application, 2021 (%)
Cancer
Others
Global Epirubicin Hydrochloride Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Epirubicin Hydrochloride Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epirubicin Hydrochloride revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Epirubicin Hydrochloride revenues share in global market, 2021 (%)
Key companies Epirubicin Hydrochloride sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Epirubicin Hydrochloride sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sterling Biotech
Zhejiang Hisun Pharma
Flavine
Teva API
Microbiopharm Japan
DZD Heze Pharma
Synbias Pharma
Intas Pharma
Humble Healthcaare
Lunan Pharmaceutical Group
Pfizer
Beijing Union Pharmaceutical Factory